| |
Case 1
|
Case 2
|
Case 3
|
Case 4
|
|---|
|
Age (years)
|
60
|
40
|
50
|
70
|
|
Sex
|
M
|
F
|
F
|
M
|
|
Chief complaints
|
Diarrhea
|
Diarrhea
|
Abdominal distention
|
Nausea
|
|
Duration of chief complains (mons)
|
17
|
3
|
1
|
2
|
|
Total protein (g/dl)
|
4
|
4.4
|
6.6
|
6.4
|
|
Albumin (g/dl)
|
2.1
|
2.9
|
3.8
|
3
|
|
LDH (IU/l)
|
165
|
156
|
187
|
150
|
|
sIL2R (U/ml)
|
963
|
1419
|
4150
|
587
|
|
Anti-gliadin/-transglutaminase tests
|
−/−
|
ne
|
ne
|
ne
|
|
Helicobacter pylori IgG antibody
|
−
|
ne
|
−
|
+
|
|
Gastrointestinal perforation
|
−
|
+ (after treatment)
|
−
|
−
|
|
Bone marrow tumour invasion
|
+ (30 %)
|
−
|
+ (30 %)
|
+ (20 %)
|
|
Clinical stage
|
IV
|
I
|
IV
|
IV
|
|
Treatment (regimen)
|
CHASE, SCT
|
THP-COP, surgery
|
CHOP, SCT
|
SMILE
|
|
Response
|
Partial response
|
No response
|
Partial response
|
Partial response
|
|
Survival times (months)
|
36, dead
|
12, dead
|
9, dead
|
9, dead
|
-
CHASE Cyclophosphamide, cytarabine, etoposide, dexametahsone, SCT Stem cell transplantation, THP-COP Pirarubicin, cyclophosphamide, vincristine, prednisolone, CHOP Cyclophosphamide, doxorubicin, vincristine, prednisolone, SMILE Dexamethasone, methotrexate, ifosfamide, L-asparaginase, etoposide; ne not examined
